News & Perspective

May 18, 2011

May 18, 2011

Experts: Regulatory issues are main reason for keeping smallpox virus

(CIDRAP News) – When the World Health Assembly (WHA) considers the fate of the remaining stocks of smallpox virus this week, the debate is likely to be framed in part by a report from a group of independent experts that says the only strong reason for keeping the virus is to satisfy strict regulatory requirements for new vaccines and antivirals.

Nov 15, 2007

Nov 15, 2007

THE PANDEMIC VACCINE PUZZLE Can we vaccinate enough people in time to matter?

Maryn McKennaContributing Writer

(CIDRAP News) – This in-depth article investigates the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. Its seven parts put advances in vaccine technology in perspective by illuminating the formidable barriers to producing an effective and widely usable vaccine in a short time frame.

Jun 01, 2005

Jun 01, 2005

WHO smallpox vaccine reserve gains support

(CIDRAP News) – The World Health Organization's (WHO's) plan to build an international emergency stockpile of smallpox vaccine drew support from member countries at their recent annual meeting in Geneva.

The World Health Assembly (WHA) "welcomed progress on WHO's work to establish a global smallpox vaccine reserve," the WHO said in a statement during the meeting, which ended last week.

Feb 15, 2002

Feb 15, 2002

Wide range of smallpox research efforts cited in WHO decision to retain virus stocks

(CIDRAP News) – A report that paved the way for the World Health Organization's (WHO's) recent recommendation to keep intact the two known collections of smallpox virus cites a wide range of ongoing research on smallpox, including genome sequencing, molecular diagnostic techniques, antiviral drugs, and new vaccines.

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»